A cell model that replicates the structure and function of the human intestine has been developed, creating an evaluation platform capable of more accurately predicting adverse effects of new drugs.

A research team led by Associate Professor Shinpei Yamaguchi and the late Professor Masako Tada of the Faculty of Science, together with Professor Yojiro Anzai and Lecturer Yohei Iizaka of the Faculty ...

February 23, 2026The Honorable Mehmet Oz, M.D.AdministratorCenters for Medicare & Medicaid Services7500 Security BoulevardBaltimore, MD 21244-1850Re: Global Benchmark for Efficient Drug Pricing (GLOBE ...

Opinion: A settlement agreement between and Federal Trade commission and Express Scripts may prove more transformative than any single pricing overhaul because it has restructured the rebate-driven ...

D cell culture technologies such as organoids and spheroids can offer a more accurate recapitulation of human physiology and ...

Some drug pricing reforms will leave independent practitioners under water, argue guest columnists Madelaine Feldman and ...

Single 2.6B-parameter model achieves state-of-the-art performance across drug discovery benchmarks while running entirely on ...

The Safe Works Access Program, known as SWAP, sends boxes of safe drug use supplies to anyone who uses unregulated street drugs in Newfoundland and Labrador — directly to their homes.

The earliest stage of drug discovery is governed by a simple constraint: there are far more possible drug-like molecules than any pharmaceutical laboratory could ever test. A new deep learning system, ...

Comments opposing Medicare's efforts to lower U.S. drug prices provide a roadmap to potential legal challenges ahead.

What kind of government doesn’t want to keep its own law-abiding population safe and secure, by locking up as many violent criminals as possible?

Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing ...